{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:52:40Z","timestamp":1792183960317,"version":"4.4.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82404022"],"award-info":[{"award-number":["No.82404022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82330084"],"award-info":[{"award-number":["No. 82330084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB063"],"award-info":[{"award-number":["2024AFB063"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2021CFA006"],"award-info":[{"award-number":["2021CFA006"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei Provincial Postdoctoral Innovation Talent Training Program"},{"name":"Basic Research Support Program of Huazhong University of Science and Technology"},{"name":"Key Research and Development Program of Hubei Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited therapeutic options and a profoundly immunosuppressive tumor microenvironment (TME). Ferroptosis, a novel form of regulated cell death driven by iron-dependent lipid peroxidation, has emerged as a promising therapeutic avenue by targeting metabolic vulnerabilities in cancer cells. Notably, key ferroptotic pathways in PDAC involve iron accumulation, lipid peroxidation, and oxidative stress. Major defense systems include the System Xc\u207b\/GSH\/GPX4, NAD (P)H-FSP1-CoQH\n                    <jats:sub>2<\/jats:sub>\n                    \/VKH\n                    <jats:sub>2<\/jats:sub>\n                    , DHODH-CoQH\n                    <jats:sub>2<\/jats:sub>\n                    , and GCH1-BH4 pathways. Ferroptosis exhibits dual roles in PDAC, demonstrating both tumor-suppressive and oncogenic effects within TME. Ferroptosis-related biomarkers show promise for PDAC diagnosis and prognosis. Novel therapeutic strategies combining ferroptosis inducers with conventional treatments and nanoparticle-based delivery systems have shown encouraging results in preclinical studies. While ferroptosis-based therapies offer potential for PDAC treatment, challenges remain in translating these approaches to clinical practice. Therefore, this review provides a comprehensive synthesis of the mechanistic insights, therapeutic potential, and associated challenges of targeting ferroptosis in PDAC. It is necessary to identify specific biomarkers, mitigate side effects, and elucidate the complex interactions between ferroptosis and TME. Integrating ferroptosis modulation with existing therapies may lead to more effective, personalized treatment strategies for PDAC.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-02987-2","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:40:19Z","timestamp":1772106019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications"],"prefix":"10.1038","volume":"12","author":[{"given":"Yurao","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-9357","authenticated-orcid":false,"given":"Guihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-2523","authenticated-orcid":false,"given":"Yuhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-7201","authenticated-orcid":false,"given":"Jun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2987_CR1","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1002\/cncr.33038","volume":"126","author":"CA McIntyre","year":"2020","unstructured":"McIntyre CA, Lawrence SA, Richards AL, Chou JF, Wong W, Capanu M, et al. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. Cancer. 2020;126:3939\u201349.","journal-title":"Cancer"},{"key":"2987_CR2","first-page":"837","volume":"11","author":"M Xue","year":"2021","unstructured":"Xue M, Shi M, Xie J, Zhang J, Jiang L, Deng X, et al. Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma. Am J Cancer Res. 2021;11:837\u201348.","journal-title":"Am J Cancer Res"},{"key":"2987_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2987_CR4","doi-asserted-by":"crossref","unstructured":"Gan B. Mitochondrial regulation of ferroptosis. J Cell Biol. 2021;220:e202105043.","DOI":"10.1083\/jcb.202105043"},{"key":"2987_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"2987_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"2987_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"2987_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.devcel.2020.06.019","volume":"54","author":"MA Perez","year":"2020","unstructured":"Perez MA, Magtanong L, Dixon SJ, Watts JL. Dietary lipids induce ferroptosis in caenorhabditiselegans and human cancer cells. Dev Cell. 2020;54:447\u201354.e4.","journal-title":"Dev Cell"},{"key":"2987_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"2987_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22:225\u201334.","journal-title":"Nat Cell Biol"},{"key":"2987_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"2987_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9:271.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608:778\u201383.","journal-title":"Nature"},{"key":"2987_CR16","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26:1447\u201357.","journal-title":"Nat Cell Biol"},{"key":"2987_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10:2.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13:342\u201355.","journal-title":"Nat Rev Cancer"},{"key":"2987_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/1055-9965.EPI-13-0733","volume":"23","author":"A Fonseca-Nunes","year":"2014","unstructured":"Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23:12\u201331.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2987_CR20","first-page":"2176","volume":"13","author":"J Lang","year":"2019","unstructured":"Lang J, Zhao X, Wang X, Zhao Y, Li Y, Zhao R, et al. Targeted co-delivery of the iron chelator deferoxamine and a HIF1\u03b1 inhibitor impairs pancreatic tumor growth. ACS Nano. 2019;13:2176\u201389.","journal-title":"ACS Nano"},{"key":"2987_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"J Du","year":"2021","unstructured":"Du J, Wang X, Li Y, Ren X, Zhou Y, Hu W, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021;12:705.","journal-title":"Cell Death Dis"},{"key":"2987_CR22","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1158\/2159-8290.CD-22-0044","volume":"12","author":"M Ravichandran","year":"2022","unstructured":"Ravichandran M, Hu J, Cai C, Ward NP, Venida A, Foakes C, et al. Coordinated transcriptional and catabolic programs support iron-dependent adaptation to RAS-MAPK pathway inhibition in pancreatic cancer. Cancer Discov. 2022;12:2198\u2013219.","journal-title":"Cancer Discov"},{"key":"2987_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20904-2","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Song X, Kuang F, Zhang Q, Xie Y, Kang R, et al. NUPR1 is a critical repressor of ferroptosis. Nat Commun. 2021;12:647.","journal-title":"Nat Commun"},{"key":"2987_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24859-2","volume":"12","author":"DM Kremer","year":"2021","unstructured":"Kremer DM, Nelson BS, Lin L, Yarosz EL, Halbrook CJ, Kerk SA, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12:4860.","journal-title":"Nat Commun"},{"key":"2987_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102962","volume":"68","author":"R No\u00e8","year":"2023","unstructured":"No\u00e8 R, Inglese N, Romani P, Serafini T, Paoli C, Calciolari B, et al. Organic Selenium induces ferroptosis in pancreatic cancer cells. Redox Biol. 2023;68:102962.","journal-title":"Redox Biol"},{"key":"2987_CR26","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218:e20201606.","DOI":"10.1084\/jem.20201606"},{"key":"2987_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19:50.","journal-title":"Mol Cancer"},{"key":"2987_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/2159-8290.CD-18-1212","volume":"9","author":"FR Auciello","year":"2019","unstructured":"Auciello FR, Bulusu V, Oon C, Tait-Mulder J, Berry M, Bhattacharyya S, et al. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov. 2019;9:617\u201327.","journal-title":"Cancer Discov"},{"key":"2987_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu D, Wang Z, Xia Y, Shao F, Xia W, Wei Y, et al. The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis. Nature. 2020;580:530\u20135.","journal-title":"Nature"},{"key":"2987_CR30","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1158\/1078-0432.CCR-20-5020","volume":"27","author":"RK Nimmakayala","year":"2021","unstructured":"Nimmakayala RK, Rauth S, Chirravuri Venkata R, Marimuthu S, Nallasamy P, Vengoji R, et al. PGC1\u03b1-mediated metabolic reprogramming drives the stemness of pancreatic precursor lesions. Clin Cancer Res. 2021;27:5415\u201329.","journal-title":"Clin Cancer Res"},{"key":"2987_CR31","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1158\/0008-5472.CAN-20-1255","volume":"80","author":"CN Rozeveld","year":"2020","unstructured":"Rozeveld CN, Johnson KM, Zhang L, Razidlo GL. KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL. Cancer Res. 2020;80:4932\u201345.","journal-title":"Cancer Res"},{"key":"2987_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tem.2021.04.012","volume":"32","author":"M Aldrovandi","year":"2021","unstructured":"Aldrovandi M, Fedorova M, Conrad M. Juggling with lipids, a game of Russian roulette. Trends Endocrinol Metab. 2021;32:463\u201373.","journal-title":"Trends Endocrinol Metab"},{"key":"2987_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"2987_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-nutr-062320-114541","volume":"42","author":"E Mishima","year":"2022","unstructured":"Mishima E, Conrad M. Nutritional and metabolic control of ferroptosis. Annu Rev Nutr. 2022;42:275\u2013309.","journal-title":"Annu Rev Nutr"},{"key":"2987_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty A, Singh T, Tyurina YY, Tyurin VA, Samovich S, Nicolas E, et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat Commun. 2021;12:2244.","journal-title":"Nat Commun"},{"key":"2987_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15:1137\u201347.","journal-title":"Nat Chem Biol"},{"key":"2987_CR37","doi-asserted-by":"crossref","unstructured":"Angeli JPF, Freitas FP, Nepachalovich P, Puentes L, Zilka O, Inague A. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401\u201310.","DOI":"10.1038\/s41586-023-06878-9"},{"key":"2987_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","volume":"29","author":"M Maiorino","year":"2018","unstructured":"Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;29:61\u201374.","journal-title":"Antioxid Redox Signal"},{"key":"2987_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong L, Ko PJ, To M, Cao JY, Forcina GC, Tarangelo A, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol. 2019;26:420\u201332.e9.","journal-title":"Cell Chem Biol"},{"key":"2987_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55050-4","volume":"14","author":"A Suda","year":"2024","unstructured":"Suda A, Umaru BA, Yamamoto Y, Shima H, Saiki Y, Pan Y, et al. Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth. Sci Rep. 2024;14:4409.","journal-title":"Sci Rep"},{"key":"2987_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07426-8","volume":"20","author":"H Blomstrand","year":"2020","unstructured":"Blomstrand H, Green H, Fredrikson M, Gr\u00e4nsmark E, Bj\u00f6rnsson B, Elander NO. Clinical characteristics and blood\/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel. BMC Cancer. 2020;20:950.","journal-title":"BMC Cancer"},{"key":"2987_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat. 2023;68:100960.","journal-title":"Drug Resist Updat"},{"key":"2987_CR43","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3724\/abbs.2022162","volume":"54","author":"Z Ye","year":"2022","unstructured":"Ye Z, Chen H, Ji S, Hu Y, Lou X, Zhang W, et al. MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors. Acta Biochim Biophys Sin. 2022;54:1599\u2013609.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2987_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbrc.2020.12.066","volume":"536","author":"NJ Hu","year":"2021","unstructured":"Hu NJ, Bai LL, Dai EY, Han L, Kang R, Li HJ, et al. Pirin is a nuclear redox-sensitive modulator of autophagy-dependent ferroptosis. Biochem Biophys Res Commun. 2021;536:100\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"2987_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"2987_CR46","doi-asserted-by":"crossref","unstructured":"Sylvester AL, Zhang DX, Ran S, Zinkevich NS. Inhibiting NADPH oxidases to target vascular and other pathologies: an update on recent experimental and clinical studies. Biomolecules. 2022;12:823.","DOI":"10.3390\/biom12060823"},{"key":"2987_CR47","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 2017;20:1692\u2013704.","journal-title":"Cell Rep"},{"key":"2987_CR48","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, et al. The Hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28:2501\u20138.e4.","journal-title":"Cell Rep"},{"key":"2987_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1158\/1541-7786.MCR-19-0691","volume":"18","author":"WH Yang","year":"2020","unstructured":"Yang WH, Huang Z, Wu J, Ding CC, Murphy SK, Chi JT. A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Mol Cancer Res. 2020;18:79\u201390.","journal-title":"Mol Cancer Res"},{"key":"2987_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2024.05.031","volume":"221","author":"D Su","year":"2024","unstructured":"Su D, Ding C, Wang R, Qiu J, Liu Y, Tao J, et al. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Free Radic Biol Med. 2024;221:136\u201354.","journal-title":"Free Radic Biol Med"},{"key":"2987_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202202161","volume":"18","author":"H Yuan","year":"2022","unstructured":"Yuan H, Xia P, Sun X, Ma J, Xu X, Fu C, et al. Photothermal nanozymatic nanoparticles induce ferroptosis and apoptosis through tumor microenvironment manipulation for cancer therapy. Small. 2022;18:e2202161.","journal-title":"Small"},{"key":"2987_CR52","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/jcmm.16196","volume":"25","author":"Y Rong","year":"2021","unstructured":"Rong Y, Gao J, Kuang T, Chen J, Li JA, Huang Y, et al. DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1-mediated antioxidant effects. J Cell Mol Med. 2021;25:2163\u201375.","journal-title":"J Cell Mol Med"},{"key":"2987_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, Gan B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun. 2018;38:12.","journal-title":"Cancer Commun"},{"key":"2987_CR54","doi-asserted-by":"publisher","first-page":"30836","DOI":"10.1074\/jbc.M109.032839","volume":"284","author":"H Liang","year":"2009","unstructured":"Liang H, Yoo SE, Na R, Walter CA, Richardson A, Ran Q. Short form glutathione peroxidase 4 is the essential isoform required for survival and somatic mitochondrial functions. J Biol Chem. 2009;284:30836\u201344.","journal-title":"J Biol Chem"},{"key":"2987_CR55","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1089\/ars.2008.2055","volume":"10","author":"SC Tosatto","year":"2008","unstructured":"Tosatto SC, Bosello V, Fogolari F, Mauri P, Roveri A, Toppo S, et al. The catalytic site of glutathione peroxidases. Antioxid Redox Signal. 2008;10:1515\u201326.","journal-title":"Antioxid Redox Signal"},{"key":"2987_CR56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.bbrc.2019.11.187","volume":"522","author":"H Wang","year":"2020","unstructured":"Wang H, Liu C, Zhao Y, Zhang W, Xu K, Li D, et al. Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells. Biochem Biophys Res Commun. 2020;522:1063\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2987_CR57","doi-asserted-by":"crossref","unstructured":"Chen HD, Ye Z, Hu HF, Fan GX, Hu YH, Li Z, et al. SMAD4 endows TGF-beta1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Acta Pharmacol Sin. 2024;45:844\u201356.","DOI":"10.1038\/s41401-023-01199-z"},{"key":"2987_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis. 2022;13:630.","journal-title":"Cell Death Dis"},{"key":"2987_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2024.01.003","volume":"212","author":"W Zhou","year":"2024","unstructured":"Zhou W, Lim A, Elmadbouh OHM, Edderkaoui M, Osipov A, Mathison AJ, et al. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Free Radic Biol Med. 2024;212:493\u2013504.","journal-title":"Free Radic Biol Med"},{"key":"2987_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107408","volume":"26","author":"D Mukherjee","year":"2023","unstructured":"Mukherjee D, Chakraborty S, Bercz L, D\u2019Alesio L, Wedig J, Torok MA, et al. Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression. iScience. 2023;26:107408.","journal-title":"iScience"},{"key":"2987_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308208","volume":"11","author":"G Li","year":"2024","unstructured":"Li G, Liao C, Chen J, Wang Z, Zhu S, Lai J, et al. Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci. 2024;11:e2308208.","journal-title":"Adv Sci"},{"key":"2987_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15:eadg3049.","journal-title":"Sci Transl Med"},{"key":"2987_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41420-023-01517-8","volume":"9","author":"R Xu","year":"2023","unstructured":"Xu R, Wang W, Zhang W. Ferroptosis and the bidirectional regulatory factor p53. Cell Death Discov. 2023;9:197.","journal-title":"Cell Death Discov"},{"key":"2987_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165747","volume":"1866","author":"JH Zhu","year":"2020","unstructured":"Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, et al. MiR-139-5p\/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K\/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165747.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2987_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1744102","volume":"2023","author":"H Li","year":"2023","unstructured":"Li H, Wei Y, Wang J, Yao J, Zhang C, Yu C, et al. Long noncoding RNA LINC00578 inhibits ferroptosis in pancreatic cancer via regulating SLC7A11 ubiquitination. Oxid Med Cell Longev. 2023;2023:1744102.","journal-title":"Oxid Med Cell Longev"},{"key":"2987_CR66","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1158\/0008-5472.CAN-20-2496","volume":"81","author":"G Sharbeen","year":"2021","unstructured":"Sharbeen G, McCarroll JA, Akerman A, Kopecky C, Youkhana J, Kokkinos J, et al. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Res. 2021;81:3461\u201379.","journal-title":"Cancer Res"},{"key":"2987_CR67","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1080\/15548627.2021.1922984","volume":"17","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Kimmelman AC. Autophagy is critical for cysteine metabolism in pancreatic cancer through regulation of SLC7A11. Autophagy. 2021;17:1561\u20132.","journal-title":"Autophagy"},{"key":"2987_CR68","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay S, Biancur DE, Parker SJ, Yamamoto K, Banh RS, Paulo JA, et al. Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11. Proc Natl Acad Sci USA. 2021;118:e2021475118.","DOI":"10.1073\/pnas.2021475118"},{"key":"2987_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102324","volume":"53","author":"G Rademaker","year":"2022","unstructured":"Rademaker G, Boumahd Y, Peiffer R, Anania S, Wissocq T, Liegeois M, et al. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biol. 2022;53:102324.","journal-title":"Redox Biol"},{"key":"2987_CR70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41420-021-00662-2","volume":"7","author":"C Huang","year":"2021","unstructured":"Huang C, Santofimia-Casta\u00f1o P, Liu X, Xia Y, Peng L, Gotorbe C, et al. NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner. Cell Death Discov. 2021;7:269.","journal-title":"Cell Death Discov"},{"key":"2987_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122447","volume":"305","author":"TJ Zhou","year":"2024","unstructured":"Zhou TJ, Zhang MM, Liu DM, Huang LL, Yu HQ, Wang Y, et al. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer. Biomaterials. 2024;305:122447.","journal-title":"Biomaterials"},{"key":"2987_CR72","doi-asserted-by":"crossref","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J. CoQ(10) and mitochondrial dysfunction in Alzheimer\u2019s disease. Antioxidants. 2024;13:191.","DOI":"10.3390\/antiox13020191"},{"key":"2987_CR73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105:651\u2013706.","journal-title":"Physiol Rev"},{"key":"2987_CR74","first-page":"932","volume":"46","author":"P Tao","year":"2021","unstructured":"Tao P, Jiang Y, Wang H, Gao G. CYP2J2-produced epoxyeicosatrienoic acids contribute to the ferroptosis resistance of pancreatic ductal adenocarcinoma in a PPARgamma-dependent manner. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46:932\u201341.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2987_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06311-z","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S, Chen J, Li P, Chen Y. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. Cell Death Dis. 2023;14:767.","journal-title":"Cell Death Dis"},{"key":"2987_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302318","volume":"10","author":"J Gong","year":"2023","unstructured":"Gong J, Liu Y, Wang W, He R, Xia Q, Chen L, et al. TRIM21-promoted FSP1 plasma membrane translocation confers ferroptosis resistance in human cancers. Adv Sci. 2023;10:e2302318.","journal-title":"Adv Sci"},{"key":"2987_CR77","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller F, Lim JKM, Bebber CM, Seidel E, Tishina S, Dahlhaus A, et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 2023;30:442\u201356.","journal-title":"Cell Death Differ"},{"key":"2987_CR78","first-page":"591","volume":"19","author":"H Fanet","year":"2021","unstructured":"Fanet H, Capuron L, Castanon N, Calon F, Vancassel S. Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry. Curr Neuropharmacol. 2021;19:591\u2013609.","journal-title":"Curr Neuropharmacol"},{"key":"2987_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Muller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41\u201353.","journal-title":"ACS Cent Sci"},{"key":"2987_CR80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13046-022-02518-8","volume":"41","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, et al. CircLRFN5 inhibits the progression of glioblastoma via PRRX2\/GCH1 mediated ferroptosis. J Exp Clin Cancer Res. 2022;41:307.","journal-title":"J Exp Clin Cancer Res"},{"key":"2987_CR81","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cac2.12281","volume":"42","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhai E, Chen J, Qian Y, Zhao R, Ma Y, et al. m(6) A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels. Cancer Commun. 2022;42:327\u201344.","journal-title":"Cancer Commun"},{"key":"2987_CR82","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351\u201360.","journal-title":"Nat Chem Biol"},{"key":"2987_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.810327","volume":"10","author":"Q Hu","year":"2022","unstructured":"Hu Q, Wei W, Wu D, Huang F, Li M, Li W, et al. Blockade of GCH1\/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to erastin-induced ferroptosis. Front Cell Dev Biol. 2022;10:810327.","journal-title":"Front Cell Dev Biol"},{"key":"2987_CR84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2018.10.012","volume":"195","author":"JT Madak","year":"2019","unstructured":"Madak JT, Bankhead A 3rd, Cuthbertson CR, Showalter HD, Neamati N. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer. Pharmacol Ther. 2019;195:111\u201331.","journal-title":"Pharmacol Ther"},{"key":"2987_CR85","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1021\/acsptsci.0c00124","volume":"3","author":"CR Cuthbertson","year":"2020","unstructured":"Cuthbertson CR, Guo H, Kyani A, Madak JT, Arabzada Z, Neamati N. The dihydroorotate dehydrogenase inhibitor brequinar is synergistic with ENT1\/2 inhibitors. ACS Pharmacol Transl Sci. 2020;3:1242\u201352.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2987_CR86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"2987_CR87","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"2987_CR88","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-023-06269-0","volume":"619","author":"E Mishima","year":"2023","unstructured":"Mishima E, Nakamura T, Zheng J, Zhang W, Mourao ASD, Sennhenn P, et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature. 2023;619:E9\u201318.","journal-title":"Nature"},{"key":"2987_CR89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107189119","volume":"119","author":"S Cui","year":"2022","unstructured":"Cui S, Simmons G Jr, Vale G, Deng Y, Kim J, Kim H, et al. FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids. Proc Natl Acad Sci USA. 2022;119:e2107189119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2987_CR90","doi-asserted-by":"crossref","unstructured":"Waters AM, Der CJ. KRAS: the critical driver and therapeutic target for pancreatic cancer. Cold Spring Harb Perspect Med. 2018;8:a031435.","DOI":"10.1101\/cshperspect.a031435"},{"key":"2987_CR91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7\u201324.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2987_CR92","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","volume":"9","author":"A Carrer","year":"2019","unstructured":"Carrer A, Trefely S, Zhao S, Campbell SL, Norgard RJ, Schultz KC, et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 2019;9:416\u201335.","journal-title":"Cancer Discov"},{"key":"2987_CR93","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.celrep.2016.07.009","volume":"16","author":"MS Padanad","year":"2016","unstructured":"Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, et al. Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis. Cell Rep. 2016;16:1614\u201328.","journal-title":"Cell Rep"},{"key":"2987_CR94","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-19-1363","volume":"80","author":"S Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay S, Goswami D, Adiseshaiah PP, Burgan W, Yi M, Guerin TM, et al. Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers. Cancer Res. 2020;80:1630\u201343.","journal-title":"Cancer Res"},{"key":"2987_CR95","doi-asserted-by":"crossref","unstructured":"Sayin VI, LeBoeuf SE, Singh SX, Davidson SM, Biancur D, Guzelhan BS, et al. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer. Elife. 2017;6:e28083.","DOI":"10.7554\/eLife.28083"},{"key":"2987_CR96","doi-asserted-by":"crossref","unstructured":"Muir A, Danai LV, Gui DY, Waingarten CY, Lewis CA, Vander Heiden MG. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition. Elife. 2017;6:e27713.","DOI":"10.7554\/eLife.27713"},{"key":"2987_CR97","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 2018;29:1756\u201373.","journal-title":"Antioxid Redox Signal"},{"key":"2987_CR98","first-page":"1182","volume":"10","author":"Z Ye","year":"2020","unstructured":"Ye Z, Hu Q, Zhuo Q, Zhu Y, Fan G, Liu M, et al. Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells. Am J Cancer Res. 2020;10:1182\u201393.","journal-title":"Am J Cancer Res"},{"key":"2987_CR99","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"2987_CR100","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847563","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Zhang X, Cui W, Liu Y, Sun QR, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. Embo Rep. 2019;20:e47563.","journal-title":"Embo Rep"},{"key":"2987_CR101","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1073\/pnas.1002459107","volume":"107","author":"S Suzuki","year":"2010","unstructured":"Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA. 2010;107:7461\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2987_CR102","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1073\/pnas.1001006107","volume":"107","author":"W Hu","year":"2010","unstructured":"Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA. 2010;107:7455\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2987_CR103","doi-asserted-by":"crossref","unstructured":"Thompson LR, Oliveira TG, Hermann ER, Chowanadisai W, Clarke SL, Montgomery MR. Distinct TP53 mutation types exhibit increased sensitivity to ferroptosis independently of changes in iron regulatory protein activity. Int J Mol Sci. 2020;21:6751.","DOI":"10.3390\/ijms21186751"},{"key":"2987_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2527210","volume":"2022","author":"H Gao","year":"2022","unstructured":"Gao H, Xie R, Huang R, Wang C, Wang Y, Wang D, et al. CIRBP regulates pancreatic cancer cell ferroptosis and growth by directly binding to p53. J Immunol Res. 2022;2022:2527210.","journal-title":"J Immunol Res"},{"key":"2987_CR105","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"J Li","year":"2022","unstructured":"Li J, Lama R, Galster SL, Inigo JR, Wu J, Chandra D, et al. Small-molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol Cancer Ther. 2022;21:535\u201345.","journal-title":"Mol Cancer Ther"},{"key":"2987_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"2987_CR107","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","volume":"13","author":"Y Qian","year":"2020","unstructured":"Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2020;13:130.","journal-title":"J Hematol Oncol"},{"key":"2987_CR108","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","volume":"144","author":"TJ Grant","year":"2016","unstructured":"Grant TJ, Hua K, Singh A. Molecular pathogenesis of pancreatic cancer. Prog Mol Biol Transl Sci. 2016;144:241\u201375.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2987_CR109","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"2987_CR110","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.7150\/ijbs.95962","volume":"20","author":"S Zhang","year":"2024","unstructured":"Zhang S, Huang J, Lan Z, Xiao Y, Liao Y, Basnet S, et al. CPEB1 controls NRF2 proteostasis and ferroptosis susceptibility in pancreatic cancer. Int J Biol Sci. 2024;20:3156\u201372.","journal-title":"Int J Biol Sci"},{"key":"2987_CR111","doi-asserted-by":"crossref","unstructured":"Guo Y, Chen T, Liang X, Gou S, Xiong J, Cui J, et al. Tumor cell derived exosomal GOT1 suppresses tumor cell ferroptosis to accelerate pancreatic cancer progression by activating Nrf2\/HO-1 axis via upregulating CCR2 expression. Cells. 2022;11:3893.","DOI":"10.3390\/cells11233893"},{"key":"2987_CR112","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3724\/abbs.2024138","volume":"57","author":"B Liu","year":"2024","unstructured":"Liu B, Chen Z, Li Z, Zhao X, Zhang W, Zhang A, et al. Hsp90\u03b1 promotes chemoresistance in pancreatic cancer by regulating Keap1-Nrf2 axis and inhibiting ferroptosis. Acta Biochim Biophys Sin. 2024;57:295\u2013309.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2987_CR113","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-21-3230","volume":"82","author":"X Wang","year":"2022","unstructured":"Wang X, Li Y, Li Z, Lin S, Wang H, Sun J, et al. Mitochondrial calcium uniporter drives metastasis and confers a targetable cystine dependency in pancreatic cancer. Cancer Res. 2022;82:2254\u201368.","journal-title":"Cancer Res"},{"key":"2987_CR114","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gendis.2020.05.004","volume":"8","author":"T Sun","year":"2021","unstructured":"Sun T, Chi JT. Regulation of ferroptosis in cancer cells by YAP\/TAZ and Hippo pathways: the therapeutic implications. Genes Dis. 2021;8:241\u20139.","journal-title":"Genes Dis"},{"key":"2987_CR115","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-023-02671-8","volume":"42","author":"T Zhou","year":"2023","unstructured":"Zhou T, Xie Y, Hou X, Bai W, Li X, Liu Z, et al. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo\/YAP1\/c-Jun axis. J Exp Clin Cancer Res. 2023;42:111.","journal-title":"J Exp Clin Cancer Res"},{"key":"2987_CR116","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572:402\u20136.","journal-title":"Nature"},{"key":"2987_CR117","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5483\/BMBRep.2013.46.3.036","volume":"46","author":"A Mielgo","year":"2013","unstructured":"Mielgo A, Schmid MC. Impact of tumour associated macrophages in pancreatic cancer. BMB Rep. 2013;46:131\u20138.","journal-title":"BMB Rep"},{"key":"2987_CR118","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol. 2020;27:420\u201335.","journal-title":"Cell Chem Biol"},{"key":"2987_CR119","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2828493","volume":"2019","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Park J, Han SJ, Lim Y, Park I, Kim JS, et al. Peroxiredoxin III protects tumor suppressor PTEN from oxidation by 15-hydroperoxy-eicosatetraenoic acid. Oxid Med Cell Longev. 2019;2019:2828493.","journal-title":"Oxid Med Cell Longev"},{"key":"2987_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102923","volume":"67","author":"L Yao","year":"2023","unstructured":"Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol. 2023;67:102923.","journal-title":"Redox Biol"},{"key":"2987_CR121","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","volume":"29","author":"J Muri","year":"2019","unstructured":"Muri J, Thut H, Bornkamm GW, Kopf M. B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis. Cell Rep. 2019;29:2731\u201344.e4.","journal-title":"Cell Rep"},{"key":"2987_CR122","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u201312.e5.","journal-title":"Cell Metab"},{"key":"2987_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Vanden Berghe T, Ravichandran KS, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13:3676.","journal-title":"Nat Commun"},{"key":"2987_CR124","doi-asserted-by":"crossref","unstructured":"Lambert A, Schwarz L, Ducreux M, Conroy T. Neoadjuvant treatment strategies in resectable pancreatic cancer. Cancers. 2021;13.","DOI":"10.3390\/cancers13184724"},{"key":"2987_CR125","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.seminoncol.2018.12.003","volume":"46","author":"M Ducreux","year":"2019","unstructured":"Ducreux M, Seufferlein T, Van Laethem JL, Laurent-Puig P, Smolenschi C, Malka D, et al. Systemic treatment of pancreatic cancer revisited. Semin Oncol. 2019;46:28\u201338.","journal-title":"Semin Oncol"},{"key":"2987_CR126","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820962117","volume":"19","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117.","journal-title":"Technol Cancer Res Treat"},{"key":"2987_CR127","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"2987_CR128","doi-asserted-by":"crossref","unstructured":"Lee B, Gibbs P. Inflammation, biomarkers and immuno-oncology pathways in pancreatic cancer. J Pers Med. 2019;9:20.","DOI":"10.3390\/jpm9020020"},{"key":"2987_CR129","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.hpb.2017.11.009","volume":"20","author":"LA Daamen","year":"2018","unstructured":"Daamen LA, Groot VP, Heerkens HD, Intven MPW, van Santvoort HC, Molenaar IQ. Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer. HPB. 2018;20:297\u2013304.","journal-title":"HPB"},{"key":"2987_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217350","volume":"610","author":"B Yu","year":"2025","unstructured":"Yu B, Shao S, Ma W. Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy. Cancer Lett. 2025;610:217350.","journal-title":"Cancer Lett"},{"key":"2987_CR131","first-page":"639","volume":"73","author":"R Ben-Ami","year":"2024","unstructured":"Ben-Ami R, Wang QL, Zhang J, Supplee JG, Fahrmann JF, Lehmann-Werman R, et al. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut. 2024;73:639\u201348.","journal-title":"Gut"},{"key":"2987_CR132","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2017.05.023","volume":"66","author":"L Shen","year":"2017","unstructured":"Shen L, Qian Y, Wu W, Weng T, Wang FXC, Hong B, et al. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Hum Pathol. 2017;66:79\u201385.","journal-title":"Hum Pathol"},{"key":"2987_CR133","first-page":"1551","volume":"19","author":"C Hufnagl","year":"2020","unstructured":"Hufnagl C, Leisch M, Weiss L, Melchardt T, Moik M, Asslaber D, et al. Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncol Lett. 2020;19:1551\u20138.","journal-title":"Oncol Lett"},{"key":"2987_CR134","doi-asserted-by":"publisher","first-page":"e073995","DOI":"10.1136\/bmj-2022-073995","volume":"383","author":"M Del Chiaro","year":"2023","unstructured":"Del Chiaro M, Sugawara T, Karam SD, Messersmith WA. Advances in the management of pancreatic cancer. BMJ. 2023;383:e073995.","journal-title":"BMJ"},{"key":"2987_CR135","first-page":"164","volume":"19","author":"N Abbaspour","year":"2014","unstructured":"Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19:164\u201374.","journal-title":"J Res Med Sci"},{"key":"2987_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00650-7","volume":"11","author":"JM Park","year":"2021","unstructured":"Park JM, Mau CZ, Chen YC, Su YH, Chen HA, Huang SY, et al. A case-control study in Taiwanese cohort and meta-analysis of serum ferritin in pancreatic cancer. Sci Rep. 2021;11:21242.","journal-title":"Sci Rep"},{"key":"2987_CR137","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1182\/blood-2018-06-815894","volume":"133","author":"CY Wang","year":"2019","unstructured":"Wang CY, Babitt JL. Liver iron sensing and body iron homeostasis. Blood. 2019;133:18\u201329.","journal-title":"Blood"},{"key":"2987_CR138","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler MU, Rivella S, Hentze MW, Galy B. A red carpet for iron metabolism. Cell. 2017;168:344\u201361.","journal-title":"Cell"},{"key":"2987_CR139","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/ajcn\/nqab217","volume":"114","author":"S Julian-Serrano","year":"2021","unstructured":"Julian-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, et al. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 2021;114:1408\u201317.","journal-title":"Am J Clin Nutr"},{"key":"2987_CR140","doi-asserted-by":"publisher","first-page":"18119","DOI":"10.1007\/s00432-023-05478-4","volume":"149","author":"L Wang","year":"2023","unstructured":"Wang L, Wu Z, Xu C, Ye H. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival. J Cancer Res Clin Oncol. 2023;149:18119\u201334.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2987_CR141","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.csbj.2022.06.046","volume":"20","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang J, Wang Y, Xu Y, Zhang S. Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment. Comput Struct Biotechnol J. 2022;20:3322\u201335.","journal-title":"Comput Struct Biotechnol J"},{"key":"2987_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00421-6","volume":"18","author":"Q Xiao","year":"2023","unstructured":"Xiao Q, Lan Z, Zhang S, Ren H, Wang S, Wang P, et al. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism. Biol Direct. 2023;18:77.","journal-title":"Biol Direct"},{"key":"2987_CR143","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/1541-7786.MCR-22-0024","volume":"20","author":"X Qiu","year":"2022","unstructured":"Qiu X, Shi Q, Zhang X, Shi X, Jiang H, Qin S. LncRNA A2M-AS1 promotes ferroptosis in pancreatic cancer via interacting with PCBP3. Mol Cancer Res. 2022;20:1636\u201345.","journal-title":"Mol Cancer Res"},{"key":"2987_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.937413","volume":"13","author":"P Tan","year":"2022","unstructured":"Tan P, Li M, Liu Z, Li T, Zhao L, Fu W. Glycolysis-related LINC02432\/Hsa-miR-98-5p\/HK2 axis inhibits ferroptosis and predicts immune infiltration, tumor mutation burden, and drug sensitivity in pancreatic adenocarcinoma. Front Pharmacol. 2022;13:937413.","journal-title":"Front Pharmacol"},{"key":"2987_CR145","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, Chandana S, Wright GP, Chung M. Pancreatic cancer: a review of current treatment and novel therapies. J Invest Surg. 2023;36:2129884.","journal-title":"J Invest Surg"},{"key":"2987_CR146","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, McArthur H, K\u00fcmmel S, Bergh J, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382:810\u201321.","journal-title":"N Engl J Med"},{"key":"2987_CR147","doi-asserted-by":"publisher","first-page":"e204564","DOI":"10.1001\/jamaoncol.2020.4564","volume":"6","author":"T Yau","year":"2020","unstructured":"Yau T, Kang YK, Kim TY, El-Khoueiry AB, Santoro A, Sangro B, et al. Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 Randomized Clinical Trial. JAMA Oncol. 2020;6:e204564.","journal-title":"JAMA Oncol"},{"key":"2987_CR148","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia P, Khorramdelazad H, Nickho H, Delbandi AA. Current and future immunotherapeutic approaches in pancreatic cancer treatment. J Hematol Oncol. 2024;17:40.","journal-title":"J Hematol Oncol"},{"key":"2987_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31:e1904197.","journal-title":"Adv Mater"},{"key":"2987_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14324-x","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Luo M, Zhang K, Zhang J, Gao T, Connell DO, et al. Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020;11:433.","journal-title":"Nat Commun"},{"key":"2987_CR151","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5361241","volume":"2022","author":"Y Liu","year":"2022","unstructured":"Liu Y, Huang P, Li Z, Xu C, Wang H, Jia B, et al. Vitamin C sensitizes pancreatic cancer cells to erastin-induced ferroptosis by activating the AMPK\/Nrf2\/HMOX1 pathway. Oxid Med Cell Longev. 2022;2022:5361241.","journal-title":"Oxid Med Cell Longev"},{"key":"2987_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1129662","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Peng X, Cen S, Yang C, Ma Z, Shi X. Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2\/GPX4 axis. Front Pharmacol. 2023;14:1129662.","journal-title":"Front Pharmacol"},{"key":"2987_CR153","doi-asserted-by":"crossref","unstructured":"Samanta K, Setua S, Kumari S, Jaggi M, Yallapu MM, Chauhan SC. Gemcitabine combination nano therapies for pancreatic cancer. Pharmaceutics. 2019;11:574.","DOI":"10.3390\/pharmaceutics11110574"},{"key":"2987_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52978-z","volume":"15","author":"V de Laat","year":"2024","unstructured":"de Laat V, Topal H, Spotbeen X, Talebi A, Dehairs J, Idkowiak J, et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun. 2024;15:8540.","journal-title":"Nat Commun"},{"key":"2987_CR155","doi-asserted-by":"crossref","unstructured":"Kim MJ, Kim HS, Kang HW, Lee DE, Hong WC, Kim JH, et al. SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer. Cells. 2023;12:2509.","DOI":"10.3390\/cells12202509"},{"key":"2987_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103200","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Xu J, Xiao M, Liang C, Hua J, Liu J, et al. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. Redox Biol. 2024;73:103200.","journal-title":"Redox Biol"},{"key":"2987_CR157","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1038\/s41418-023-01188-z","volume":"30","author":"H Ma","year":"2023","unstructured":"Ma H, Chen X, Mo S, Zhang Y, Mao X, Chen J, et al. Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma. Cell Death Differ. 2023;30:1988\u20132004.","journal-title":"Cell Death Differ"},{"key":"2987_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.865655","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang Z, Cheng J, Pan H, Lin T, Shen X, et al. Platelet-vesicles-encapsulated RSL-3 enable anti-angiogenesis and induce ferroptosis to inhibit pancreatic cancer progress. Front Endocrinol. 2022;13:865655.","journal-title":"Front Endocrinol"},{"key":"2987_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101132","volume":"27","author":"A Huang","year":"2024","unstructured":"Huang A, Li Q, Shi X, Gao J, Ma Y, Ding J, et al. An iron-containing nanomedicine for inducing deep tumor penetration and synergistic ferroptosis in enhanced pancreatic cancer therapy. Mater Today Bio. 2024;27:101132.","journal-title":"Mater Today Bio"},{"key":"2987_CR160","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.actbio.2022.02.006","volume":"142","author":"G Zhang","year":"2022","unstructured":"Zhang G, Li N, Qi Y, Zhao Q, Zhan J, Yu D. Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monitoring of pancreatic cancer. Acta Biomater. 2022;142:284\u201397.","journal-title":"Acta Biomater"},{"key":"2987_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01999-9","volume":"23","author":"J Diao","year":"2024","unstructured":"Diao J, Jia Y, Dai E, Liu J, Kang R, Tang D, et al. Ferroptotic therapy in cancer: benefits, side effects, and risks. Mol Cancer. 2024;23:89.","journal-title":"Mol Cancer"},{"key":"2987_CR162","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao J, Jia Y, Mahmut D, Deik AA, Jeanfavre S, Clish CB, et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell. 2023;186:732\u201347.e16.","journal-title":"Cell"},{"key":"2987_CR163","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"2987_CR164","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","volume":"9","author":"BA Carlson","year":"2016","unstructured":"Carlson BA, Tobe R, Yefremova E, Tsuji PA, Hoffmann VJ, Schweizer U, et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016;9:22\u201331.","journal-title":"Redox Biol"},{"key":"2987_CR165","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cmet.2023.05.008","volume":"35","author":"M Ferrer","year":"2023","unstructured":"Ferrer M, Mourikis N, Davidson EE, Kleeman SO, Zaccaria M, Habel J, et al. Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia. Cell Metab. 2023;35:1147\u201362.e7.","journal-title":"Cell Metab"},{"key":"2987_CR166","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"2987_CR167","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365\u201378.e6.","journal-title":"Cancer Cell"},{"key":"2987_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300881","volume":"10","author":"F Jiang","year":"2023","unstructured":"Jiang F, Jia K, Chen Y, Ji C, Chong X, Li Z, et al. ANO1-mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts. Adv Sci. 2023;10:e2300881.","journal-title":"Adv Sci"},{"key":"2987_CR169","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"2987_CR170","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"2987_CR171","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR172","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","volume":"13","author":"D Zheng","year":"2023","unstructured":"Zheng D, Li J, Yan H, Zhang G, Li W, Chu E, et al. Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharm Sin B. 2023;13:2826\u201343.","journal-title":"Acta Pharm Sin B"},{"key":"2987_CR173","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2022.0110","volume":"38","author":"L Zhang","year":"2023","unstructured":"Zhang L, Cui T, Wang X. The interplay between autophagy and regulated necrosis. Antioxid Redox Signal. 2023;38:550\u201380.","journal-title":"Antioxid Redox Signal"},{"key":"2987_CR174","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25:379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2987_CR175","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106\u201321.","journal-title":"Cell Mol Immunol"},{"key":"2987_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D. The mechanism of HMGB1 secretion and release. Exp Mol Med. 2022;54:91\u2013102.","journal-title":"Exp Mol Med"},{"key":"2987_CR177","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41586-019-0885-0","volume":"565","author":"J Nassour","year":"2019","unstructured":"Nassour J, Radford R, Correia A, Fust\u00e9 JM, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659\u201363.","journal-title":"Nature"},{"key":"2987_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14:648.","journal-title":"Cell Death Dis"},{"key":"2987_CR179","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res"},{"key":"2987_CR180","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.","journal-title":"Signal Transduct Target Ther"},{"key":"2987_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1416-5","volume":"10","author":"YB Sun","year":"2019","unstructured":"Sun YB, Zhao H, Mu DL, Zhang W, Cui J, Wu L, et al. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis. 2019;10:167.","journal-title":"Cell Death Dis"},{"key":"2987_CR182","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","volume":"38","author":"RA Aglietti","year":"2017","unstructured":"Aglietti RA, Dueber EC. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 2017;38:261\u201371.","journal-title":"Trends Immunol"},{"key":"2987_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1213995","volume":"11","author":"F Chen","year":"2023","unstructured":"Chen F, Kang R, Liu J, Tang D. Mechanisms of alkaliptosis. Front Cell Dev Biol. 2023;11:1213995.","journal-title":"Front Cell Dev Biol"},{"key":"2987_CR184","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","volume":"154","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, et al. JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice. Gastroenterology. 2018;154:1480\u201393.","journal-title":"Gastroenterology"},{"key":"2987_CR185","doi-asserted-by":"crossref","unstructured":"Zeng S, P\u00f6ttler M, Lan B, Gr\u00fctzmann R, Pilarsky C, Yang H. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20:4504.","DOI":"10.3390\/ijms20184504"},{"key":"2987_CR186","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32:71\u201387.e7.","journal-title":"Cancer Cell"},{"key":"2987_CR187","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pan.2016.12.010","volume":"17","author":"P Dauer","year":"2017","unstructured":"Dauer P, Nomura A, Saluja A, Banerjee S. Microenvironment in determining chemo-resistance in pancreatic cancer: neighborhood matters. Pancreatology. 2017;17:7\u201312.","journal-title":"Pancreatology"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-02987-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-02987-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-02987-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:02:20Z","timestamp":1773914540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-02987-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":187,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2987"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-02987-2","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a review based solely on previously published literature. It did not involve human participants, animals, or identifiable personal data; therefore, ethical approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors agree with the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"117"}}